This innovative bladder cancer diagnostic kit uses urine samples to achieve 88.8 % sensitivity, promising early detection and ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.

AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...

AstraZeneca (NASDAQ:AZN) has reached a significant milestone with the U.S. approval of its drug Imfinzi for adult patients ...

AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

"Bladder cancer is a common cancer, but many people may not be aware ... and change the way you need to pee—in the most ...

is the most common form of bladder cancer. After the tumor is surgically removed, patients typically receive BCG to help boost their immune system in eliminating any remaining cancer cells. However, ...

A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of a prospective multicenter study.The approach — which outperformed the ...